Comprehensive Analysis to Address the Spread of Tuberculosis
DOI:
Abstract
This research explores the elevated incidence of tuberculosis (TB) in Myanmar, where the burden of the disease dramatically surpasses the worldwide average of 500 cases per 100,000 individuals. The research seeks to investigate elements leading to TB prevalence, recognize obstacles to control measures, and suggest practical recommendations. A mixed methods strategy was employed, integrating quantitative information from health statistics in Yangon, Mandalay, and the rural regions of Chin and Shan States with qualitative information gathered from interviews with healthcare professionals and impacted communities. The study results indicate that poverty, malnutrition, limited access to health services, and a lack of awareness are major factors contributing to elevated TB rates, exacerbated by the rise of multidrug-resistant TB (MDR-TB). Insufficient health care systems and cultural prejudices also hinder successful TB management. The research emphasizes the necessity for focused interventions, such as enhancing access to healthcare services, boosting public awareness, and establishing thorough TB screening initiatives. The research highlights the importance of tackling the underlying causes of poverty and malnutrition to lower TB vulnerability. These results have important consequences for expanding TB control initiatives, not just in Myanmar but also in other nations encountering comparable socio-economic issues. Future studies ought to concentrate on assessing the efficacy of the suggested interventions and investigating creative approaches to enhance access to TB treatment while decreasing stigma.
Downloads
Views : 194
Downloads : 318
References
World Health Organization, Global Tuberculosis Report 2023. Geneva, Switzerland: WHO, 2023. [Online]. Available: https: //www.who.int/publications/i/item/978924067550. [Accessed: 25, Aug. 2024].
R. Nightingale, F. Carlin, J. Meghji, K. McMullen, D. Evans, M. M. van der Zalm, M. G. Anthony, et al., “post-TB heapost-TB wellbeing,” International Journal of Tuberculosis and Lung Disease, vol. 27, no. 4, pp. 248–283, Apr. 2023.
S. G. Mpagama et al., “The burden and determinants of post-TB lung disease,” International Journal of Tuberculosis and Lung Disease, vol. 25, pp. 846–853, 2021.
J. C. Mery, P. J. Dodd, S. Banu, et al., “Estimating the contribution of subclinical tuberculosis disease to transmission an individual patient data analysis from prevalence surveys,” medRxiv, 2022.
H. D. Shah, M. N. Khatib, Z. Q. Syed, A. M. Gaidhane, S. Yasobant, K. Narkhede, P. Bhavsar, J. Patel, A. Sinha, T. Puwar, S. Saha, and D. Saxena, “Gaps and interventions across the diagnostic care cascade of TB patients at the level of patient, community, and health system: A qualitative review of the literature,” Tropical Medicine and Infectious Disease, vol. 7, no. 7, p. 136, Jul. 2022.
T. Li, X. Du, J. Kang, D. Luo, X. Liu, and Y. Zhao, “Patient, diagnosis, and treatment delays among tuberculosis patients before and during COVID-19 epidemic - China, 2018-2022,” China CDC Weekly, vol. 5, no. 12, pp. 259–265, 2023.
K. Dheda, T. Perumal, H. Moultrie, R. Perumal, A. Esmail, A. J. Scott, Z. Udwadia, K. C. Chang, J. Peter, A. Pooran, A. von Delft, D. von Delft, N. Martinson, M. Loveday, S. Charalambous, E. Kachingwe, W. Jassat, C. Cohen, S. Tempia, K. Fennelly, and M. Pai, “The intersecting pandemics of tuberculosis and COVID-19: Population-level and patient-level impact, clinical presentation, and corrective interventions,” The Lancet Respiratory Medicine, vol. 10, no. 6, pp. 603–622, 2022.
L. Roberts, “How COVID hurt the fight against other dangerous diseases,” Nature, vol. 592, pp. 502–504, 2021.
P. L. Aung, K. M. Win, H. M. Win Maung, and K. L. Show, “Determinants of correct knowledge on tuberculosis transmission and self-reported tuberculosis prevalence among general population aged 15–49 years in Myanmar,” PLoS One, vol. 18, no. 8, p. e0290470, Aug. 2023.
S. T. Aung, W. Wint Nyunt, M. M. Moe, H. Lin Aungid, and T. Lwin, “The fourth national tuberculosis prevalence survey in Myanmar,” PLOS Global Public Health, vol. 2, 2022.
A. K. J. Teo, S. R. Singh, K. Prem, L. Y. Hsu, and S. Yi, “Duration and determinants of delayed tuberculosis diagnosis and treatment in high-burden countries: A mixed-methods systematic review and meta-analysis,” Respiratory Research, vol. 22, no. 1, pp. 1–28, 2021.
T. K. A. Teibo, R. L. d. P. Andrade, R. J. Rosa, et al., “Geo-spatial high-risk clusters of tuberculosis in the global general population: A systematic review,” BMC Public Health, vol. 23, 2023.
N. Dookie, S. L. Ngema, R. Perumal, N. Naicker, N. Padayatchi, and K. Naidoo, “The changing paradigm of drug-resistant tuberculosis treatment: Successes, pitfalls, and future perspectives,” Clinical Microbiology Reviews, vol. 35, no. 4, 2022.
A. Ortno, T. Yamanaka, P. Nguhiu, N. Nishikiori, I. Garcia Baena, K. Floyd, et al., “Costs incurred by people receiving tuberculosis treatment in low-income and middle-income countries: A meta-regression analysis,” The Lancet Global Health, vol. 11, no. 10, pp. e1640–e1647, 2023.
M. N. T. Khaing, N. U, L. Maw, et al., “Out-of-pocket payment and catastrophic health expenditure of tuberculosis patients in accessing care at public-private mix clinics in Myanmar, 2022,” Infectious Diseases of Poverty, vol. 13, 2024.
Y. Hu, Z. Lin, S. Jiao, and R. Zhang, “High-Density Communities and Infectious Disease Vulnerability: A Built Environment Perspective for Sustainable Health Development,” Buildings, vol. 14, no. 1, 2024.
Y. Hu, Z. Lin, S. Jiao, and R. Zhang, “High-Density Communities and Infectious Disease Vulnerability: A Built Environment Perspective for Sustainable Health Development,” Buildings, vol. 14, no. 1, 2024.
A. K. J. Teo, S. R. Singh, K. Prem, L. Y. Hsu, and S. Yi, “Duration and determinants of delayed tuberculosis diagnosis and treatment in high-burden countries: a mixed-methods systematic review and meta-analysis,” Respiratory Research, vol. 22, no. 1, 2021.
Ministry of Health and Sports, Myanmar, “National Strategic Plan for Tuberculosis Control 2021-2025”, Ministry of Health and Sports, Myanmar, 2022. Available: https: //www.mohs.gov.mm. [Accessed: 28, Aug. 2024].
T-A. Nguyen, A. K. J. Teo, Y. Zhao, M. Quelapio, J. Hill, and F. Morishita, “Population-wide active case finding as a strategy to end TB,” Lessons Learnt on the Road to Ending TB – A Joint Series, vol. 46, no. 101047, 2024.
A. Khanna, R. Saha, and N. Ahmad, “National TB elimination programme - What has changed,” Indian Journal of Medical Microbiology, vol. 42, pp. 103–107, 2023.
Global Fund, “Supporting Myanmar's Tuberculosis Control Program: Progress and Impact”, Global Fund Report, Geneva, Switzerland, 2023. Available: https: //www.theglobalfund.org
WHO, “Progress and Challenges in Tuberculosis Control in Myanmar”, World Health Organization, Geneva, Switzerland, 2023. Available: https: //www.who.int. [Accessed: 28, Aug. 2024].
P. MacPherson, K. Shanaube, M. D. Phiri, et al., “Community-based active-case finding for tuberculosis: navigating a complex minefield,” BMC Global Public Health, vol. 2, 2024.
R. N. Soko, R. M. Burke, H. R. A. Feasey, W. Sibanda, M. Nliwasa, M. Y. R. Henrion, M. Khundi, P. J. Dodd, C.-C. Ku, G. Kawalazira, A. T. Choko, T. H. Divala, E. L. Corbett, and P. MacPherson, “Effects of coronavirus disease pandemic on tuberculosis notifications, Malawi,” Emerging Infectious Diseases, vol. 27, no. 7, 2021.
S. K. Brode, R. Dwilow, D. Kunimoto, D. Menzies, and F. A. Khan, “Chapter 8: Drug-resistant tuberculosis,” Canadian Journal of Respiratory, Critical Care, and Sleep Medicine, vol. 6, pp. 109–128, 2022.
Z. Z. Sultana, F. U. Hoque, J. Beyene, et al., “HIV infection and multidrug-resistant tuberculosis: a systematic review and meta-analysis,” BMC Infectious Diseases, vol. 21, no. 1, 2021.
M. F. Sazali, S. S. S. A. Rahim, A. H. Mohammad, F. Kadir, A. O. Payus, R. Avoi, M. S. Jeffree, A. Omar, M. Y. Ibrahim, A. Atil, N. M. Tuah, R. Dapari, M. G. Lansing, A. A. A. Rahim, and Z. I. Azhar, “Improving tuberculosis medication adherence: The potential of integrating digital technology and health belief model,” Tuberculosis and Respiratory Diseases (Seoul), vol. 86, no. 2, pp. 82–93, 2023.
M. Park, S. Jeong, Y. Park, S. Kim, Y. Kim, E. Kim, and S. Y. Kong, “Influencing factors of delayed diagnosis of COVID-19 in Gangwon, South Korea,” International Journal of Environmental Research and Public Health, vol. 21, no. 5, 2024.
S. R. Shrivastava, P. S. Bobhate, P. B. Petkar, H. G. Mendhe, and G. R. Bandre, “Strengthening tuberculosis control among migrant workers,” Tropical Medicine and Infectious Disease, vol. 9, no. 11, 2024.
